Test Foretells Limb Loss

OCTOBER 01, 2004

The hemoglobin A1C (HbA1C) blood test can predict whether partial foot amputation will succeed in diabetics with foot ulcers or whether a below-the-knee amputation will be necessary, according to the findings of a study presented at the American Orthopaedic Foot and Ankle Society's annual meeting (July 29, 2004). Although the finger-stick test diabetics take every day gives a blood-sugar value for that moment, the HbA1C test gives a more long-term assessment of how sugar levels have been controlled over several months. A majority of laboratories consider HbA1C values between 3% and 6% as normal.

In the current study, the researchers compared data from 21 patients with a failed partial foot amputation and 21 similar patients with a successful amputation. Age, sex, smoking, pulse in the foot, and HbA1C were factored into the study. The results showed that an HbA1C value of >10% strongly indicated that a partial foot amputation would fail to heal, compared with values of <7% that usually forecast success. Lead researcher Alastair Younger, MD, stressed, however, that a high HbA1C should not result in an automatic below-the-knee amputation. Instead, surgeons should refer the patient to an endocrinologist or take other steps to improve sugar level prior to surgery.



SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.